Loading...
Market
How many participants will regain significant arm mobility in Neuralink's trial by end of 2025?
2
Resolution / Starting Odds
0 • 25%
1-5 • 25%
6-10 • 25%
More than 10 • 25%
Trial results published by Neuralink or verified by independent medical journals
Story
Elon Musk's Neuralink Launches Trial for N1 Implant to Control Assistive Robotic Arm
Nov 25, 2024, 06:14 PM
Neuralink, the brain-computer interface (BCI) company founded by Elon Musk, has announced the approval and launch of a new feasibility trial. The trial will test the use of Neuralink's N1 Implant to control an assistive robotic arm. This marks an important first step in the development of brain-computer interfaces, with the potential to restore both digital and physical freedom for individuals with disabilities.
View original story
Similar markets
0-2 • 25%
3-4 • 25%
5-6 • 25%
Trial not completed • 25%
Less than 10 • 25%
10 to 20 • 25%
21 to 30 • 25%
More than 30 • 25%
Restoration of hand movement • 25%
Restoration of leg movement • 25%
Improvement in speech • 25%
Other • 25%
0-4 • 25%
5-9 • 25%
10-14 • 25%
Less than 5 • 25%
5 to 9 • 25%
10 to 14 • 25%
15 or more • 25%
Less than 5 • 25%
5 to 9 • 25%
10 to 14 • 25%
15 or more • 25%
0-4 • 25%
5-9 • 25%
10-14 • 25%
15 or more • 25%
1-2 • 25%
3-4 • 25%
5-6 • 25%
7 or more • 25%
0-10 • 25%
11-50 • 25%
51-100 • 25%
More than 100 • 25%
0-4 • 25%
5-9 • 25%
10-14 • 25%
15 or more • 25%
Positive outcome • 25%
Negative outcome • 25%
Inconclusive outcome • 25%
Trial not completed • 25%
Yes, in the US • 25%
Yes, internationally • 25%
Yes, both in the US and internationally • 25%
No • 25%